amlodipine / celecoxib Oral Tablet [Consensi]
- RxCUI
- 2049590
- RxNorm name
- amlodipine / celecoxib Oral Tablet [Consensi]
- Term type
- SBDF
- Status
- Active
- Updated
- 2026-11-08 10:05:36
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 082018
- Active start
- 082018
- Multiple ingredient
- YES
- Branded
- YES
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Tablet | 317541 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| celecoxib | 140587 |
| amlodipine | 17767 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | amLODIPine / celecoxib Oral Tablet [Consensi] | 1 | NAMES |
| RxNorm Name | amlodipine / celecoxib Oral Tablet [Consensi] | 1 | NAMES |
| TTY | SBDF | 1 | ATTRIBUTES |
| RxCUI | 2049590 | 1 | CODES |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | M01AH | Coxibs | ATC1-4 | celecoxib | |
| ATC | C08CA | Dihydropyridine derivatives | ATC1-4 | amlodipine | |
| ATC | C08CA | Dihydropyridine derivatives | ATC1-4 | amlodipine / celecoxib | |
| ATC | L01XX | Other antineoplastic agents | ATC1-4 | celecoxib | |
| FDASPL | D004095 | Dihydropyridines | CHEM | has_chemical_structure | amlodipine |
| FDASPL | N0000175566 | Calcium Channel Blocker | EPC | has_epc | amlodipine |
| FDASPL | N0000175421 | Dihydropyridine Calcium Channel Blocker | EPC | has_epc | amlodipine |
| FDASPL | N0000175722 | Nonsteroidal Anti-inflammatory Drug | EPC | has_epc | celecoxib |
| FDASPL | N0000000069 | Calcium Channel Antagonists | MOA | has_moa | amlodipine |
| FDASPL | N0000000160 | Cyclooxygenase Inhibitors | MOA | has_moa | celecoxib |
| FDASPL | N0000190114 | Cytochrome P450 3A Inhibitors | MOA | has_moa | amlodipine |
| MEDRT | D017311 | Amlodipine | CHEM | has_ingredient | amlodipine |
| MEDRT | D000068579 | Celecoxib | CHEM | has_ingredient | celecoxib |
| MEDRT | D011125 | Adenomatous Polyposis Coli | DISEASE | may_treat | celecoxib |
| MEDRT | D000788 | Angina Pectoris, Variant | DISEASE | may_treat | amlodipine |
| MEDRT | D001172 | Arthritis, Rheumatoid | DISEASE | may_treat | celecoxib |
| MEDRT | D003324 | Coronary Artery Disease | DISEASE | may_treat | amlodipine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | celecoxib |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | amlodipine |
| MEDRT | D004412 | Dysmenorrhea | DISEASE | may_treat | celecoxib |
| MEDRT | D006973 | Hypertension | DISEASE | may_treat | amlodipine |
| MEDRT | D007022 | Hypotension | DISEASE | ci_with | amlodipine |
| MEDRT | D010003 | Osteoarthritis | DISEASE | may_treat | celecoxib |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | celecoxib |
| MEDRT | D013167 | Spondylitis, Ankylosing | DISEASE | may_treat | celecoxib |
| MEDRT | N0000008288 | Cyclooxygenase 2 Inhibitors | MOA | has_moa | celecoxib |
| MEDRT | N0000020065 | L-Calcium Channel Receptor Antagonists | MOA | has_moa | amlodipine |
| MEDRT | N0000008375 | Coronary Arterial Vasodilation | PE | has_pe | amlodipine |
| MEDRT | N0000178477 | Decreased Blood Pressure | PE | ci_pe | amlodipine |
| MEDRT | N0000178477 | Decreased Blood Pressure | PE | has_pe | amlodipine |
| MEDRT | N0000008836 | Decreased Prostaglandin Production | PE | has_pe | celecoxib |
| MEDRT | N0000000045 | Fecal Excretion | PK | has_pk | celecoxib |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | has_pk | celecoxib |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | celecoxib |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| NAMES | Tallman Synonym | amLODIPine / celecoxib Oral Tablet [Consensi] |